Kaipa M, Agrawal DK. Cost-efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics with Greatest Risk for Cardiovascular Disease. ccm [Internet]. 2026 Apr. 16 [cited 2026 Jun. 21];10(2):71-8. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/16687